Prostate Cancer Research
A second omnibus health-care bill-this one called the Public Health Improvement Act (H.R. 2498)-was passed quietly at the end of the 2000 session, with a prostate cancer section included. That section was originally a free-standing bill called
A second omnibus health-care billthis one called the Public Health ImprovementAct (H.R. 2498)was passed quietly at the end of the 2000 session, with aprostate cancer section included. That section was originally a free-standingbill called the Prostate Cancer Research and Prevention Act (S. 1243). Sponsoredby Sen. Bill Frist, md (R-Tenn.), the legislation instructs the CDC toinaugurate a grant program aimed at finding out how men and their physiciansdecide whether prostate cancer screening is appropriate for them. In the future,there could be grants for screening of low-income men.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025
April 15th 2025Steven E. Finkelstein, MD, DABR, FACRO discuses how Prolaris distinguishes itself from other genomic biomarker platforms by providing uniquely actionable clinical information that quantifies the absolute benefit of androgen deprivation therapy when added to radiation therapy, offering clinicians a more precise tool for personalizing prostate cancer treatment strategies.
